coronary artery atherosclerotic haert disease
Conditions
Interventions
Observation group:None
Sponsors
Beijing Anzhen Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Aged 18 and above; 2. Diagnosed with coronary artery atherosclerotic heart disease; 3. Coronary artery bypass grafting surgery at Beijing Anzhen Hospital and collaborating research institutions
Exclusion criteria
Exclusion criteria: 1. Patients with combined connective tissue diseases; 2. Patients with malignant tumors; 3. Patients with other major surgeries at the same time; 4. Incomplete preoperative imaging and laboratory tests; 5. Contraindicated for surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Left common carotid artery stenosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| LVEF;LVEDD;LVESD;Left atrial diameter;Aortic Stenosis;Aortic regurgitation;Mitral Valve Stenosis;Mitral Valve Regurgitation ;Tricuspid Valve Stenosis;Tricuspid Valve Regurgitation;Aortic Bicuspid valve;Pericardial effusion;Left internal carotid artery stenosis;Left external carotid artery stenosis;Right common carotid artery stenosis;Right internal carotid artery stenosis;Right external carotid artery stenosis;Left vertebral artery stenosis;Right vertebral artery stenosis;ICU time;Postoperative recovery time;Postoperative Cerebral hemorrhage;Postoperative Cerebral infarction;Postoperative CRRT;Postoperative Myocardial Infarction;Postoperative Atrial fibrillation;Cardiac tamponade;Revascularization;Postoperative IABP;Postoperative ECMO;Postoperative Lung infection;Pleural effusion;Respiratory failure;Postoperative hemorrhage;In-hospital Death;B-type natriuretic peptide;cTnI;NE%;LYM%;RBC;Hb;PLT;HbA1c%;T3;T4;TSH;PT;APTT;D-Dimer;ALT;AST;TP;Urea;Cr;GFR;HDL-c;LDL-c;CRP; | — |
Countries
China
Contacts
Public ContactHongjia Zhang
Beijing Anzhen Hospital
Outcome results
None listed